BEIJING (Reuters) -A tie-up between a Chinese research institute and tech company said on Monday that it aims to implant its brain chip into 13 people by the end of this year, in a move that could see ...
USF medical engineering professors Dr. Richard Heller and Dr. Mark Jaroszeski have spent more than three decades developing a ...
In April 2025, Isomorphic Labs raised a $600 million in its first-ever external funding round, led by Thrive Capital. Alphabet’s Isomorphic Labs is preparing to launch human trials of AI-designed ...
The next human trial for Neuralink is coming soon. It will be the second patient to be given the company's renowned brain chip, but some changes will arrive and set it apart from the first one. It was ...
University of Wisconsin researchers opened a new path to curing Parkinson’s disease through grafting brain cells into the brains of macaque monkeys. The research, conducted at the Wisconsin National ...
A recent scientific breakthrough has seen lab-grown kidneys successfully functioning in a human trial. This promising development has far-reaching implications for organ transplant procedures and the ...
95% of clinical trials fail because animal testing is no substitute for human biology - Vivodyne’s robotics platform grows thousands of human tissues daily, directly tackling the biological gap behind ...
Recent human trials of a new one-year-long immune-based treatment for post-polio syndrome, which can strike polio survivors years after the initial infection and be very debilitating, have produced ...
A new experimental vaccine for nipah virus has successfully completed its first human trial. The vaccine was well-tolerated ...
This is an archived article and the information in the article may be outdated. Please look at the time stamp on the story to see when it was last updated. (NewsNation) — Bad news for the tooth fairy: ...
Companies are racing to create a safe, effective vaccine at record speed. The world's leading drug companies, universities and governments are racing to develop a vaccine for COVID-19, the disease ...
Alphabet’s Isomorphic Labs is preparing to launch human trials of AI-designed drugs, its president, Colin Murdoch, told Fortune. Born from DeepMind’s AlphaFold breakthrough, the company is pairing ...